Minsheng Group Shaoxing Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is HOMOHARRINGTONINE, with a corresponding US DMF Number 30158.
Remarkably, this DMF maintains an Active status since its submission on December 30, 2015, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of July 28, 2016, and payment made on February 24, 2016, indicating their dedication to facilitating drug approvals, Categorized as Type II